RU94024562A - Antibody, polynucleotide, cell, method of producing an antibody - Google Patents
Antibody, polynucleotide, cell, method of producing an antibodyInfo
- Publication number
- RU94024562A RU94024562A RU94024562/13A RU94024562A RU94024562A RU 94024562 A RU94024562 A RU 94024562A RU 94024562/13 A RU94024562/13 A RU 94024562/13A RU 94024562 A RU94024562 A RU 94024562A RU 94024562 A RU94024562 A RU 94024562A
- Authority
- RU
- Russia
- Prior art keywords
- hiv
- antibody
- antibodies
- amino acid
- acid sequence
- Prior art date
Links
- 102000004965 antibodies Human genes 0.000 title claims 5
- 108090001123 antibodies Proteins 0.000 title claims 5
- 229920000023 polynucleotide Polymers 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 210000004027 cells Anatomy 0.000 claims 2
- 102000005614 monoclonal antibodies Human genes 0.000 claims 2
- 108010045030 monoclonal antibodies Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 108010092799 EC 2.7.7.49 Proteins 0.000 claims 1
- 102000033147 ERVK-25 Human genes 0.000 claims 1
- 210000004408 Hybridomas Anatomy 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 claims 1
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 claims 1
- 229960000070 antineoplastic Monoclonal antibodies Drugs 0.000 claims 1
- 230000000295 complement Effects 0.000 claims 1
- 230000001419 dependent Effects 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 229960000060 monoclonal antibodies Drugs 0.000 claims 1
- 230000003472 neutralizing Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims 1
- 210000003369 syncitium Anatomy 0.000 claims 1
Claims (1)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1992/007111 WO1993004090A1 (en) | 1991-08-22 | 1992-08-24 | Hiv immunotherapeutics |
US92/07111 | 1992-08-24 | ||
US08/039457 | 1993-04-22 | ||
PCT/US1993/007967 WO1994004574A1 (en) | 1991-08-22 | 1993-08-24 | Hiv immunotherapeutics |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94024562A true RU94024562A (en) | 1996-03-27 |
RU2134724C1 RU2134724C1 (en) | 1999-08-20 |
Family
ID=22236878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94024562A RU2134724C1 (en) | 1992-08-24 | 1993-08-24 | Humanized antibody and method of preparation thereof, polynucleotyl (versions), and hybridon cell line (versions) |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2134724C1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6580570B2 (en) * | 2013-09-06 | 2019-09-25 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Methods for improving antibody stability |
-
1993
- 1993-08-24 RU RU94024562A patent/RU2134724C1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH06502539A (en) | Neutralizing human monoclonal antibody specific for the V3 loop and CD-4 binding site of HIV-1 GP120 | |
JP3855071B2 (en) | Anti-HIV monoclonal antibody | |
AT398080B (en) | IMMORTALIZED CELL LINE, METHOD FOR THEIR PRODUCTION AND METHOD FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES, AND DIAGNOSTIC METHODS AND MEANS | |
CA2094611A1 (en) | Hiv immunotherapeutics | |
DE3853779T2 (en) | HIV-1 NEUTRALIZING MONOCLONAL ANTIBODIES. | |
RU93005284A (en) | MONOCLONAL CELL LINES, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS, ANTIBODY FRAGMENT | |
US5854400A (en) | Monoclonal antibodies which neutralize HIV-1 infection | |
US20070292390A1 (en) | Broadly Cross-Reactive Hiv-1 Neutralizing Human Monoclonal Antibodies | |
EP0295803B1 (en) | Monoclonal antibodies | |
CA2170034A1 (en) | Recombinant humanized anti-human immunodeficiency virus antibody | |
WO1997046697A3 (en) | Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections | |
US5981278A (en) | Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS | |
DE60215676T2 (en) | Against a peptide that mimics a cryptic epitope of GP41 from HIV-1 targeted body | |
CN110483636B (en) | Humanized anti-HIVgp 120 specific antibody Z166 and application method thereof | |
RU94024562A (en) | Antibody, polynucleotide, cell, method of producing an antibody | |
Sugano et al. | Human monoclonal antibody against glycoproteins of human immunodeficiency virus | |
CA2122044A1 (en) | Hiv immunotherapeutics | |
AU629847B2 (en) | Monoclonal antibody for inhibiting cell infection by hiv viruses | |
CN1172717C (en) | Method for treating AIDS and its preparing method | |
RU2007140569A (en) | AN ANTIBODY OR ITS FRAGMENT HAVING A NEUTRALIZING ACTIVITY AGAINST HIV, BUT NOT ABOUT IL2 | |
WO1993019786A1 (en) | High affinity, strongly neutralizing monoclonal antibodies against the cd-4 binding site of gp120 of human immunodeficiency virus | |
RU2000132226A (en) | HUMANIZED ANTIBODIES THAT RECOGNIZE VEROTOXIN II AND THE CELL PRODUCING LINE THEREOF | |
JP4310498B2 (en) | Human IgM antibody that induces apoptosis in HIV-infected cells and therapeutic agent for HIV infection | |
CN1238499C (en) | Antibody against AIDS virus O and its production cell series and use | |
RU96107899A (en) | RECOMBINANT ORIGINAL ANTIBODY TO THE VIRUS OF HUMAN IMMUNODEFFICIEF |